Skip to content
Search

Latest Stories

COVID-19 backlog not likely to be cleared by 2025, even with 30% capacity boost

COVID-19 backlog not likely to be cleared by 2025, even with 30% capacity boost
Photo: iStock

Experts underscore the need to improve healthcare system resilience to reduce the effects of any future emergencies   

NHS England will not be able to clear the COVID-19 backlog before the end of 2025 even if the system capacity is increased by 30 per cent compared to pre-pandemic levels, according to a new study published in the Lancet.


Researchers from the Universities of Edinburgh and Strathclyde evaluated the impact of the pandemic on NHS waiting times for elective hospital care.

At the end of October 2022, there were more than 7.2 million patient referrals waiting for treatment in England, an increase of 2·6 million from February 2020, when the total pending referrals was 4·6 million.

In January 2012, the number of pending referrals was 2·4 million, and the list increased by about 2·2 million in the eight years before the pandemic between January 2012 and February 2020.

The statistics indicate that the service was already struggling to keep up with the demand many years before the pandemic, and the disease outbreak only aggravated the problem, said Dr Syed Ahmar Shah from the University of Edinburgh’s Usher Institute, who led the study.

However, the experts assumed that the true backlog could be much higher, as large numbers of patients have still not come forward for care.

Their models estimated more than 10 million missing referrals from the beginning of the COVID-19 pandemic to Oct 31, 2022.

NHS England's COVID recovery plan aims to deliver around 30 per cent more elective activity by 2024/25 than before the pandemic, through a range of measures, including extra staff and increased use of the independent sector.

Even with this much increase in system capacity, several years would be needed to clear the backlog, the researchers said.

They suggested that the system capacity should be increased by more than 10 per cent to reverse the increasing trend in waiting lists.

The experts underscored the need to improve health-care system resilience to minimise the effects of any future emergencies on the provision of routine care.

“Moving ahead, it is evident that we cannot afford to leave our healthcare systems strained; instead, we must enhance their resilience to ensure better preparedness for any future emergencies,” Dr Shah added.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less